Marketing Content

The dilemma of untangling cause and effect is perhaps best encapsulated by the chicken-or-egg paradox. It may provide cocktail party banter, but to an evolutionary

Admirable advances in genetic medicine have recently stoked hopes that precision therapeutics may be on the way for patients living with rare diseases. But in

You may have heard that human serum is one of the most important tools in today’s laboratory, but let’s look at why. What is human

Rare diseases are a paradoxic — they are both uncommon and common. And understanding them may help us to gain insights into more ordinary diseases. If a

A plain language summary (PLS)—also known as a lay summary or trial results summary—is a piece of writing that briefly explains the who, what, when,

An estimated 300 million people live globally with chronic infection due to hepatitis B virus (HBV); about 862,000 of these individuals live in the U.S.1,2

To meet enrollment goals, we launched outreach campaigns to our existing RA patient member community and leveraged social media’s demographic targeting capabilities to engage additional

Many study sponsors find themselves doubling study timelines simply to meet patient enrollment goals. But extending a study to focus on enrolling and retaining patients

The process to get a drug, vaccine, or medical device approved in the US may at first seem labyrinthine, but there is a method to

Our mission is to elevate patient engagement in medical research, and to solve challenges for researchers. The more people engage in studies that advance research